搜索临床试验以:卡罗妥昔单抗 (TRC105)
总计115个结果
-
Brown UniversityBristol-Myers Squibb; Rhode Island Hospital; Oncoceutics, Inc.终止
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo完全的
-
University Hospital, BordeauxUniversity of Bordeaux完全的
-
Tibotec, IncTibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA完全的
-
Tibotec Pharmaceuticals, Ireland完全的
-
French National Agency for Research on AIDS and...Merck Sharp & Dohme LLC; Janssen-Cilag Tibotec完全的
-
National Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)主动,不招人晚期恶性实体瘤 | 难治性恶性实体瘤 | 复发性腹膜恶性间皮瘤 | 复发性胸膜恶性间皮瘤 | 不可切除的实体瘤 | 晚期胸膜恶性间皮瘤 | 晚期腹膜恶性间皮瘤美国
-
National Cancer Institute (NCI)完全的IIIA 期肺癌非小细胞癌 AJCC v7 | IIIB 期肺癌非小细胞癌 AJCC v7 | IV 期肺癌非小细胞癌 AJCC v7 | III 期肺癌非小细胞癌 AJCC v7 | 局部晚期肺非鳞状非小细胞癌 | III 期肺腺癌 AJCC v7 | III 期肺大细胞癌 AJCC v7 | IIIA 期肺腺癌 AJCC v7 | IIIA 期肺大细胞癌 AJCC v7 | IIIB 期肺腺癌 AJCC v7 | IIIB 期肺大细胞癌 AJCC v7 | IV 期肺腺癌 AJCC v7 | IV 期肺大细胞癌 AJCC v7美国
-
National Cancer Institute (NCI)招聘中肺腺癌 | III 期肺癌 AJCC v8 | 肺非鳞状非小细胞癌 | 肺大细胞癌美国